Retrospective analysis of diffuse large B-cell lymphoma treated with the R-CHOP regimen at a Malaysian tertiary hospital

This study provides key insights into the clinical characteristics and treatment outcomes of Malaysian patients with DLBCL managed with the R-CHOP regimen. Age, presence of B symptoms, disease stage, baseline serum albumin, and lactate dehydrogenase levels were identified as significant prognostic markers that may help predict survival in newly diagnosed DLBCL cases. Larger, prospective trials with prolonged follow-up are necessary to validate these findings.